Both infants were admitted and discharged multiple times with consistent concerns for failure to thrive (FTT) and aspiration. Twin B was incidentally found to have asymptomatic hypocalcaemia and ...

This organization has no public members. You must be a member to see who’s a part of this organization.

Independent biopharmaceutical company Specialised Therapeutics (ST) welcomes the registration of YORVIPATH® ...

Citation Sample Size/Inclusion Criteria Method/Duration of Cooling Follow-up Findings 27 234 term infants; 116 randomly selected for cooling and 118 selected for control. Sixteen infants were lost ...

SINGAPORE, Feb. 21, 2025 /PRNewswire/ — Independent biopharmaceutical company Specialised Therapeutics (ST) welcomes the registration of YORVIPATH ® (palopegteriparatide) by the Therapeutic Goods ...